These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 27575947)

  • 1. Neurobehavioral deficits in the KIKO mouse model of Friedreich's ataxia.
    McMackin MZ; Henderson CK; Cortopassi GA
    Behav Brain Res; 2017 Jan; 316():183-188. PubMed ID: 27575947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Friedreich's ataxia: clinical aspects and pathogenesis.
    Pandolfo M
    Semin Neurol; 1999; 19(3):311-21. PubMed ID: 12194387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel GAA-repeat-expansion-based mouse model of Friedreich's ataxia.
    Anjomani Virmouni S; Ezzatizadeh V; Sandi C; Sandi M; Al-Mahdawi S; Chutake Y; Pook MA
    Dis Model Mech; 2015 Mar; 8(3):225-35. PubMed ID: 25681319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug repositioning screening identifies etravirine as a potential therapeutic for friedreich's ataxia.
    Alfedi G; Luffarelli R; Condò I; Pedini G; Mannucci L; Massaro DS; Benini M; Toschi N; Alaimo G; Panarello L; Pacini L; Fortuni S; Serio D; Malisan F; Testi R; Rufini A
    Mov Disord; 2019 Mar; 34(3):323-334. PubMed ID: 30624801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Friedreich's ataxia associated with mitochondrial myopathy: clinicopathologic report.
    Gallagher CL; Waclawik AJ; Beinlich BR; Harding CO; Pauli RM; Poirer J; Pandolfo M; Salamat MS
    J Child Neurol; 2002 Jun; 17(6):453-6. PubMed ID: 12174969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine therapy-mediated neuroprotection in a Friedreich's ataxia mouse model.
    Kemp KC; Cerminara N; Hares K; Redondo J; Cook AJ; Haynes HR; Burton BR; Pook M; Apps R; Scolding NJ; Wilkins A
    Ann Neurol; 2017 Feb; 81(2):212-226. PubMed ID: 28009062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: a cross-sectional analysis of baseline data.
    Reetz K; Dogan I; Costa AS; Dafotakis M; Fedosov K; Giunti P; Parkinson MH; Sweeney MG; Mariotti C; Panzeri M; Nanetti L; Arpa J; Sanz-Gallego I; Durr A; Charles P; Boesch S; Nachbauer W; Klopstock T; Karin I; Depondt C; vom Hagen JM; Schöls L; Giordano IA; Klockgether T; Bürk K; Pandolfo M; Schulz JB
    Lancet Neurol; 2015 Feb; 14(2):174-82. PubMed ID: 25566998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generalized chorea in two patients harboring the Friedreich's ataxia gene trinucleotide repeat expansion.
    Hanna MG; Davis MB; Sweeney MG; Noursadeghi M; Ellis CJ; Elliot P; Wood NW; Marsden CD
    Mov Disord; 1998 Mar; 13(2):339-40. PubMed ID: 9539351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional recovery in a Friedreich's ataxia mouse model by frataxin gene transfer using an HSV-1 amplicon vector.
    Lim F; Palomo GM; Mauritz C; Giménez-Cassina A; Illana B; Wandosell F; Díaz-Nido J
    Mol Ther; 2007 Jun; 15(6):1072-8. PubMed ID: 17375064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Friedreich's ataxia--a case of aberrant transcription termination?
    Butler JS; Napierala M
    Transcription; 2015; 6(2):33-6. PubMed ID: 25831023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential biomarker identification for Friedreich's ataxia using overlapping gene expression patterns in patient cells and mouse dorsal root ganglion.
    McMackin MZ; Durbin-Johnson B; Napierala M; Napierala JS; Ruiz L; Napoli E; Perlman S; Giulivi C; Cortopassi GA
    PLoS One; 2019; 14(10):e0223209. PubMed ID: 31665133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiomyopathy of Friedreich's ataxia: use of mouse models to understand human disease and guide therapeutic development.
    Payne RM; Pride PM; Babbey CM
    Pediatr Cardiol; 2011 Mar; 32(3):366-78. PubMed ID: 21360265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frataxin and frataxin deficiency in Friedreich's ataxia.
    Wilson RB
    J Neurol Sci; 2003 Mar; 207(1-2):103-5. PubMed ID: 12614940
    [No Abstract]   [Full Text] [Related]  

  • 14. Liver Growth Factor (LGF) Upregulates Frataxin Protein Expression and Reduces Oxidative Stress in Friedreich's Ataxia Transgenic Mice.
    Calatrava-Ferreras L; Gonzalo-Gobernado R; Reimers D; Herranz AS; Casarejos MJ; Jiménez-Escrig A; Regadera J; Velasco-Martín J; Vallejo-Muñoz M; Díaz-Gil JJ; Bazán E
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stress-Induced Mouse Model of the Cardiac Manifestations of Friedreich's Ataxia Corrected by AAV-mediated Gene Therapy.
    Salami CO; Jackson K; Jose C; Alyass L; Cisse GI; De BP; Stiles KM; Chiuchiolo MJ; Sondhi D; Crystal RG; Kaminsky SM
    Hum Gene Ther; 2020 Aug; 31(15-16):819-827. PubMed ID: 32646255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow transplantation stimulates neural repair in Friedreich's ataxia mice.
    Kemp KC; Hares K; Redondo J; Cook AJ; Haynes HR; Burton BR; Pook MA; Rice CM; Scolding NJ; Wilkins A
    Ann Neurol; 2018 Apr; 83(4):779-793. PubMed ID: 29534309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early VGLUT1-specific parallel fiber synaptic deficits and dysregulated cerebellar circuit in the KIKO mouse model of Friedreich ataxia.
    Lin H; Magrane J; Clark EM; Halawani SM; Warren N; Rattelle A; Lynch DR
    Dis Model Mech; 2017 Dec; 10(12):1529-1538. PubMed ID: 29259026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Friedreich's ataxia--yesterday, today and tomorrow.
    Chakravarty A
    Neurol India; 2003 Jun; 51(2):176-82. PubMed ID: 14570998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin and small molecule agonists of the tissue-protective erythropoietin receptor increase FXN expression in neuronal cells in vitro and in Fxn-deficient KIKO mice in vivo.
    Miller JL; Rai M; Frigon NL; Pandolfo M; Punnonen J; Spencer JR
    Neuropharmacology; 2017 Sep; 123():34-45. PubMed ID: 28504123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting lipid peroxidation and mitochondrial imbalance in Friedreich's ataxia.
    Abeti R; Uzun E; Renganathan I; Honda T; Pook MA; Giunti P
    Pharmacol Res; 2015 Sep; 99():344-50. PubMed ID: 26141703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.